帮助 关于我们

返回检索结果

2型糖尿病小鼠模型的建立与评价
Establishment and Assessment of Mice Models of Type 2 Diabetes Mellitus

查看参考文献18篇

文摘 目的通过高热量饮食与小剂量多次腹腔注射链脲佐菌素(STZ)的方法建立2型糖尿病小鼠模型。方法采用随机数字表将30只雄性昆明种(KM)小鼠随机分为对照组和模型组(n=15),模型组小鼠饲喂高热量饲料1个月后,连续2~4 d腹腔注射30 mg/kg体重剂量的STZ;对照组则饲喂标准维持鼠料及注射等量柠檬酸盐缓冲液。观测小鼠食水量、体重等一般情况,并于造模后第1、2、4、5、12、21周尾尖采血检测血糖值,在小鼠血糖趋于稳定时检测血清胰岛素(INS),血浆总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL),血浆糖化血红蛋白(HbA1c)含量,并进行口服葡萄糖耐量试验。结果模型组小鼠存活率为100%。与对照组相比,模型组小鼠注射STZ后体重逐渐下降并于第4周降到最低,此后逐渐回升,直到第21周仍显著低于对照组(t=3.160,P=0.006)。模型组小鼠在造模后血糖水平均明显高于造模前和对照组(P均<0.05);随着时间推移,血糖值也在不断上升,至21周,小鼠血糖值仍旧保持在较高水平的(26.38±1.34)mmol/L。造模后第4周,模型组小鼠的空腹血糖为(11.86±3.33)mmol/L,明显高于对照组的(6.37±1.27)mmol/L(t=-3.830,P=0.002);空腹血清胰岛素水平与对照组差异无统计学意义[(5.73±0.24)mU/L比(5.48±0.32)mU/L;t=-0.863,P=0.416];胰岛素敏感指数为0.0145±0.0039,明显低于对照组的0.0267±0.0039(t=4.414,P=0.003)。造模后第6周,模型组小鼠在口服灌胃葡萄糖0、30、60、120 min后的血糖分别为(15.35±1.82)、(26.45±1.07)、(25.58±1.46)、(26.15±1.00)mmol/L,均明显高于对照组的(6.88±1.75)(t=-8.203,P=0.000)、(17.65±2.94)(t=-6.884,P=0.000)、(13.18±2.04)(t=-12.110,P=0.000)、(7.37±3.40)mmol/L(t=-12.969,P=0.000)。造模后第8周,模型组小鼠的血清TC和TG水平分别为(3.83±0.06)和(2.20±0.20)mmol/L,明显高于对照组的(3.10±0.10)(t=11.000,P=0.000)和(0.90±0.10)mmol/L(t=10.070,P=0.000);HDL水平为(2.03±0.06)mmol/L,明显低于对照组的(2.48±0.02)mmol/L(t=11.662,P=0.000);LDL水平上升但差异无统计学意义[(0.34±0.08)mmol/L比(0.26±0.02)mmol/L;t=1.680,P=0.168];HbA1c含量为(7.30±0.31)%,明显高于对照组的(4.40±0.32)%(t=-11.587,P=0.000)。结论采用高热量饮食与小剂量多次腹腔注射STZ的方法成功建立了2型糖尿病KM小鼠模型。
其他语种文摘 To establish type 2 diabetes mellitus(T2DM)KM mouse models via the combined use of high-calorie diet and multiple administration of low-dose streptozotocin(STZ). Methods Based on the randomized number table,30 KM mice were equally and randomly divided into 2 groups:modeling group and control group. Mice in the modeling group were given foods with high calories for one month and injected with 30 mg/kg STZ via the left lower abdominal cavity for 2-4 consecutive days,while mice in the control group were fed with standard maintenance foods and the same dose of citrate buffer solution. The general conditions including food and water intake and mice weight were recorded. Blood glucose level was measured 1,2,4,5,12,and 21 weeks after STZ injection. When the glucose level became stabilized,the serum insulin and blood lipids [including total cholesterol(TC),triacylglycerol(TG),high-density lipoprotein(HDL) and low-density lipoprotein(LDL)],and hemoglobin a1c (HbA1c)were measured,and oral glucose tolerance test were performed. Results The modeling group had a 100% survival rate. After STZ injection,the body weight of mice in the modeling group reached the peak in the forth week,and later the growth rate decreased,still significantly lower than that of control group mice till the 21~(st) week(t=3.160,P=0.006). Their blood glucose level was significantly higher than that of mice before STZ injection and in the control group(all P<0.05);as time went on,it was also rising,and it remained high till the 21~(st) week [(26.38±1.34)mmol/L]. In the 4~(th) week,the fasting blood glucose of mice in the modeling group was(11.86±3.33)mmol/L,which was significantly higher than that of mice in the control group [(6.37±1.27)mmol/L](t=-3.830,P=0.002). Fasting serum insulin of mice in the modeling group showed no significant difference compared with control group [(5.73±0.24)mU/L vs.(5.48±0.32)mU/L;t=-0.863,P=0.416]. Insulin sensitivity index was 0.0145±0.0039,which was significantly lower than that(0.0267±0.0039)in control group(t=4.414,P=0.003). In the 6~(th) week,the blood glucose levels of mice in the modeling group were(15.35±1.82),(26.45±1.07),(25.58±1.46),and(26.15±1.00)mmol/L 0,30,60,and 120 min after oral gavage of D-glucose,which were all significantly higher than those in the control group [(6.88±1.75)(t=-8.203,P=0.000),(17.65±2.94)(t=-6.884,P=0.000),(13.18±2.04)(t=-12.110,P=0.000),and(7.37±3.40)mmol/L(t=-12.969,P=0.000)]. In the 8~(th) week,serum TC and TG levels of mice in the modeling group were(3.83±0.06)and(2.20±0.20)mmol/L,which were significantly higher than those in the control group [(3.10±0.10)(t=11.000,P=0.000)and(0.90±0.10)mmol/L(t=10.070,P=0.000)]. HDL level of mice in the modeling group was(2.03±0.06)mmol/L,which was significantly lower than that in the control group [(2.48±0.02)mmol/L;t=11.662,P=0.000]. LDL level was increased but showed no significant difference [(0.34±0.08)mmol/L vs.(0.26±0.02)mmol/L](t=1.680,P=0.168). HbA1c content of mice in the modeling group was(7.30±0.31)%,which was significantly higher than that(4.40±0.32)% in the control group(t=-11.587,P=0.000). Conclusion KM mice models of T2DM were successfully established after high-calorie diet and multiple administration of low-dose STZ.
来源 中国医学科学院学报 ,2017,39(3):324-329 【核心库】
DOI 10.3881/j.issn.1000-503x.2017.03.005
关键词 2型糖尿病 ; 小鼠模型 ; 链脲佐菌素 ; 评价指标
地址

中国农业科学院生物技术研究所分子生物学研究室, 北京, 100081

语种 中文
文献类型 研究性论文
ISSN 1000-503X
学科 内科学
基金 中国农业科学院科技创新工程专项经费
文献收藏号 CSCD:6021054

参考文献 共 18 共1页

1.  张宏波. 糖尿病的健康管理. 内蒙古中医药,2014,33(15):111-112 CSCD被引 1 次    
2.  Prakash J. Nondiabetic renal disease in patients 15 with type 2 diabetes mellitus. Text Nephrol,2014:158-165 CSCD被引 1 次    
3.  樊志奇. 四氧嘧啶制备糖尿病小鼠模型的影响因素研究. 时珍国医国药,2010,21(8):1948-1949 CSCD被引 9 次    
4.  Furman B L. Streptozotocin-induced diabetic models in mice and rats. Curr Protoc Pharmacol,2015,70:5.47.1-20 CSCD被引 27 次    
5.  Luo J. Nongenetic mouse models of non-insulin-dependent diabetes mellitus. Metabolism,1998,47(6):663-668 CSCD被引 34 次    
6.  高秀莹. 2型糖尿病鼠类模型的研究进展. 中国实验动物学报,2014(4):71-76 CSCD被引 15 次    
7.  中华医学会糖尿病学会. 中国2型糖尿病防治指南:2010年版,2011 CSCD被引 3 次    
8.  Kong Y. Linker engineering for fusion protein construction:improvement and characterization of a GLP-1 fusion protein. Enzyme Microb Technol,2015,82(1):105-109 CSCD被引 1 次    
9.  王勇. EDTA抗凝剂简易配制法. 医学信息,2010,5(8):2243 CSCD被引 1 次    
10.  Zimmet P. Diabetes mellitus statistics on prevalence and mortality:facts and fallacies. Nat Rev Endocrinol,2016,12(10):616-622 CSCD被引 18 次    
11.  田婷. 2型糖尿病动物模型研究概况. 医学综述,2011,17(6):905-908 CSCD被引 7 次    
12.  王洪莹. 2型糖尿病动物模型的建立,2007 CSCD被引 3 次    
13.  雒晓燕. 2型糖尿病患者血脂四项水平变化的分析. 基层医学论坛,2010,14(20):599 CSCD被引 1 次    
14.  杨家钰. 血浆脂蛋白a对糖尿病足发病影响的系统评价和Meta分析. 公共卫生与预防医学,2016,27(2):17-21 CSCD被引 1 次    
15.  Kannel W B. Usefulness of the triglyceride-high-density lipoprotein versus the cholesterol-high-density lipoprotein ratio for predicting insulin resistance and cardiometabolic risk(from the Framingham Offspring Cohort). Am J Cardiol,2008,101(4):497-501 CSCD被引 5 次    
16.  徐立民. 糖尿病患者血脂4项和凝血4项指标的变化及临床意义. 中国伤残医学,2013,1:98-99 CSCD被引 1 次    
17.  Jialal I. Cholesterol,triglyceride and high-density lipoprotein cholesterol levels in non-insulin-dependent diabetes in the young. S Afr Med J,1982,61(11):393-395 CSCD被引 1 次    
18.  李志勤. 健康体检人群血脂四项水平的调查研究. 医学理论与实践,2011,24(3):363-364 CSCD被引 1 次    
引证文献 10 篇

1 刘羽 益气养阴活血法对糖尿病合并脑梗死大鼠糖脂代谢影响的研究 时珍国医国药,2018,29(7):1562-1565
CSCD被引 1 次

2 李丹丹 黄芪多糖联合二甲双胍对衰老2型糖尿病模型小鼠肝脏糖脂代谢的影响 中国中医药信息杂志,2019,26(2):47-51
CSCD被引 7 次

显示所有10篇文献

论文科学数据集
PlumX Metrics
相关文献

 作者相关
 关键词相关
 参考文献相关

版权所有 ©2008 中国科学院文献情报中心 制作维护：中国科学院文献情报中心
地址：北京中关村北四环西路33号 邮政编码：100190 联系电话：(010)82627496 E-mail:cscd@mail.las.ac.cn 京ICP备05002861号-4 | 京公网安备11010802043238号